Collplant Biotechnologies Ltd (CLGN) — Capital Reinvestment Ratio
Collplant Biotechnologies Ltd (CLGN) has a Capital Reinvestment Ratio of 0.04x as of September 2023, meaning it reinvests 0% of its operating cash flow ($6.78 Million) in capital expenditures ($243.00K). Check how tangible is Collplant Biotechnologies Ltd's equity to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Collplant Biotechnologies Ltd Capital Reinvestment Ratio (2021–2021)
This chart tracks Collplant Biotechnologies Ltd's Capital Reinvestment Ratio across 1 annual periods. For the full cash flow conversion analysis, see Collplant Biotechnologies Ltd operating cash flow efficiency.
Annual Capital Reinvestment Ratio for Collplant Biotechnologies Ltd (2021–2021)
Year-by-year Capital Reinvestment Ratio for Collplant Biotechnologies Ltd from 2021 to 2021. See free cash flow generation of Collplant Biotechnologies Ltd to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2021 | 0.57x | $2.50 Million | $1.43 Million | — |